Healthcare Stocks Aren’t a Shelter From the Tariff Storm - Barron's
1. Trump announced tariffs on pharmaceuticals, impacting drug industry stocks. 2. BMY's stock dropped 4.6% following the tariff announcements. 3. Analysts recommend selling pharma stocks amid tariff fears. 4. Managed care stocks performed well, contrasting with pharma declines. 5. Tariffs could complicate healthcare investment strategies moving forward.